Maryam Aminu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Maryam Aminu has a total of 56 co-authors. Here are the top co-authors by number of shared publications:
- Andrew Duncan Steele
Enterics, Diagnostics, Genomics & Epidemiology, Gates Foundation, Seattle, WA 98109, USA
5 shared publications A. A. Ahmad
Department of Microbiology, Faculty of Science, Faculty of Veterinary Medicine, Ahmadu Bello University, Zaria, Nigeria
2 shared publicationsJ. Dewar
MRC Diarrhoeal Pathogens Research Unit, University of Limpopo Medunsa Campus, Pretoria
2 shared publicationsJ. U. Umoh
Department of Veterinary Public Health and Preventative Medicine, Faculty of Veterinary Medicine, Ahmadu Bello University, Zaria, Nigeria
2 shared publicationsM D Esona
MRC/MEDUNSA Diarrhoeal Pathogens Research Unit, University of Limpopo, Medunsa Campus, Pretoria, South Africa
2 shared publicationsM. D. Esona
Gastroenteritis and Respiratory Viruses Laboratory Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
2 shared publications
Latest Publications
- Open Access
- 27 July 2026
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Seroprevalence of measles-specific IgM and IgG antibodies among children (0–12 years) with measles-like symptoms: a hospital-based cross-sectional study in Northeast Nigeria
Nigeria has one of the highest measles burdens and the lowest vaccination coverage worldwide. The WHO AFRO region, including Nigeria, is currently working towards a revised target of eliminating measles by 2030. Nigeria's strategy includes improving MCV1 coverage at 9 months, supplemental immunization for children aged 9-59 months, and intensified case-based surveillance. Recently, MCV2 was introduced and is being piloted. Achieving at least 95% coverage with MCV2 at 15 months is essential for herd immunity. Despite these efforts, measles outbreaks persist, worsened by armed conflicts and the COVID-19 pandemic in Northeast Nigeria which disrupts health infrastructures and ultimately affects immunization activities. This study evaluates serological patterns and confirms measles infection among symptomatic children attending healthcare facilities in Northeast Nigeria. By integrating serology with socio-demographic and clinical risk factors, we seek to evaluate the serological profile and identify proportion of susceptible individuals among symptomatic children in some selected clinical settings in Northeast Nigeria. Children with clinically suspected measles cases were recruited from selected primary healthcare centres (PHC) in Yobe, Borno and Adamawa between November 2022-July 2023. The study analysed serum samples for measles-specific IgM antibodies (n = 558) and measles-specific IgG antibodies (n = 372). IgM antibodies were determined using the EUROIMMUN measles virus IgM ELISA kit, and IgG antibodies were determined using the Calbiotech measles IgG kit. Odds Ratio (OR) and 95% Confidence Intervals (CI) were calculated from 2 × 2 tables using a Univariate Logistic Regression model. The association between measles and socio-demographic and risk factors was analysed using chi-square. Statistical significance was set at P ≤ 0.05. In this study, seroprevalence was defined by the presence of IgM to indicate recent infection and IgG to indicate past exposure or immunity. The results showed a seroprevalence of 29.2% for measles IgM and 32.8% for measles IgG. Measles IgM and IgG antibodies were detected more among males compared to females, with a seroprevalence of 30.6% and 33.3% respectively. No significant association was observed between sex and Measles virus seropositivity for either IgM or IgG (P > 0.05). Although the odds ratio for males was 1.23, the 95% confidence interval (0.82-1.82) indicated that this difference was not statistically significant. The highest IgM and IgG antibodies were observed amongst children aged 1-3 years with a prevalence of 40.8% and 46.5% respectively. Vaccination was associated with a significant reduction in the odds of measles infection (OR 0.30; 95% CI, 0.20-0.44; P ≤ 0.005). This study is limited by potential selection and recall biases. By focusing exclusively on children presenting with measles-like symptoms, the findings are not representative of the general paediatric population. Furthermore, reliance on parental recall for vaccination history introduces a high likelihood of information bias. Our study identifies a high frequency of measles seropositivity among symptomatic children in selected healthcare facilities in Adamawa, Borno and Yobe states. While this study highlights a high prevalence of non-vaccination among symptomatic children, further research should focus on the need for localised investigation into immunization history in symptomatic cases. Not applicable.
- 27 July 2026
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Open AccessSeroprevalence of measles-specific IgM and IgG antibodies among children (0–12 years) with measles-like symptoms: a hospital-based cross-sectional study in Northeast Nigeria
Nigeria has one of the highest measles burdens and the lowest vaccination coverage worldwide. The WHO AFRO region, including Nigeria, is currently working towards a revised target of eliminating measles by 2030. Nigeria's strategy includes improving MCV1 coverage at 9 months, supplemental immunization for children aged 9-59 months, and intensified case-based surveillance. Recently, MCV2 was introduced and is being piloted. Achieving at least 95% coverage with MCV2 at 15 months is essential for herd immunity. Despite these efforts, measles outbreaks persist, worsened by armed conflicts and the COVID-19 pandemic in Northeast Nigeria which disrupts health infrastructures and ultimately affects immunization activities. This study evaluates serological patterns and confirms measles infection among symptomatic children attending healthcare facilities in Northeast Nigeria. By integrating serology with socio-demographic and clinical risk factors, we seek to evaluate the serological profile and identify proportion of susceptible individuals among symptomatic children in some selected clinical settings in Northeast Nigeria. Children with clinically suspected measles cases were recruited from selected primary healthcare centres (PHC) in Yobe, Borno and Adamawa between November 2022-July 2023. The study analysed serum samples for measles-specific IgM antibodies (n = 558) and measles-specific IgG antibodies (n = 372). IgM antibodies were determined using the EUROIMMUN measles virus IgM ELISA kit, and IgG antibodies were determined using the Calbiotech measles IgG kit. Odds Ratio (OR) and 95% Confidence Intervals (CI) were calculated from 2 × 2 tables using a Univariate Logistic Regression model. The association between measles and socio-demographic and risk factors was analysed using chi-square. Statistical significance was set at P ≤ 0.05. In this study, seroprevalence was defined by the presence of IgM to indicate recent infection and IgG to indicate past exposure or immunity. The results showed a seroprevalence of 29.2% for measles IgM and 32.8% for measles IgG. Measles IgM and IgG antibodies were detected more among males compared to females, with a seroprevalence of 30.6% and 33.3% respectively. No significant association was observed between sex and Measles virus seropositivity for either IgM or IgG (P > 0.05). Although the odds ratio for males was 1.23, the 95% confidence interval (0.82-1.82) indicated that this difference was not statistically significant. The highest IgM and IgG antibodies were observed amongst children aged 1-3 years with a prevalence of 40.8% and 46.5% respectively. Vaccination was associated with a significant reduction in the odds of measles infection (OR 0.30; 95% CI, 0.20-0.44; P ≤ 0.005). This study is limited by potential selection and recall biases. By focusing exclusively on children presenting with measles-like symptoms, the findings are not representative of the general paediatric population. Furthermore, reliance on parental recall for vaccination history introduces a high likelihood of information bias. Our study identifies a high frequency of measles seropositivity among symptomatic children in selected healthcare facilities in Adamawa, Borno and Yobe states. While this study highlights a high prevalence of non-vaccination among symptomatic children, further research should focus on the need for localised investigation into immunization history in symptomatic cases. Not applicable.
- Open Access
- 1 January 2026
- Published by AOSIS in Journal of Public Health in Africa
- Vol. 17 (1) , 6
Measles and rubella seropositivity among suspected measles cases in northwestern region of Nigeria
Background: Measles is a highly contagious and vaccine-preventable viral disease that results from infection with measles virus. The clinical picture of measles may resemble rubella and other viral exanthems (fever-rash disease). Aim: This study aimed to determine the measles seropositivity rate among suspected measles cases and evidence of rubella among measles seronegative cases in the seven states of northwestern Nigeria. Setting: The data were generated from the Medical Laboratory of Yusuf Dantsoho Memorial Hospital Kaduna. The laboratory receives samples from Disease Notification and Surveillance officers of local governments of the seven states of northwestern Nigerian. Methods: The study was cross-sectional where secondary data of measles case-based surveillance were analysed. The study population comprised of individuals with suspected measles infection living in the seven states of northwestern Nigerian. Results: Out of 3090 samples tested for measles immunoglobulin M (IgM) antibodies, 1553 (50.3%) tested positive, while 1537 (49.7%) tested negative. Among the negative cases, 1521 were further tested for rubella IgM antibodies, with 157 (10.3%) testing positive. Conclusion: This high measles seropositivity is concerning considering the ease of access to measles vaccines available at every primary, secondary and even tertiary health facilities spread across northwestern Nigeria. Contribution: This study reveals that measles virus circulates with high endemicity in the region, with 50.3% serologically confirmed cases among samples from persons suspected to have measles sent for testing. Additionally, 10.3% of individuals suspected having measles but tested negative were found to test positive for rubella.
- 1 January 2026
- Published by AOSIS in Journal of Public Health in Africa
- Vol. 17 (1) , 6
Open AccessMeasles and rubella seropositivity among suspected measles cases in northwestern region of Nigeria
Background: Measles is a highly contagious and vaccine-preventable viral disease that results from infection with measles virus. The clinical picture of measles may resemble rubella and other viral exanthems (fever-rash disease). Aim: This study aimed to determine the measles seropositivity rate among suspected measles cases and evidence of rubella among measles seronegative cases in the seven states of northwestern Nigeria. Setting: The data were generated from the Medical Laboratory of Yusuf Dantsoho Memorial Hospital Kaduna. The laboratory receives samples from Disease Notification and Surveillance officers of local governments of the seven states of northwestern Nigerian. Methods: The study was cross-sectional where secondary data of measles case-based surveillance were analysed. The study population comprised of individuals with suspected measles infection living in the seven states of northwestern Nigerian. Results: Out of 3090 samples tested for measles immunoglobulin M (IgM) antibodies, 1553 (50.3%) tested positive, while 1537 (49.7%) tested negative. Among the negative cases, 1521 were further tested for rubella IgM antibodies, with 157 (10.3%) testing positive. Conclusion: This high measles seropositivity is concerning considering the ease of access to measles vaccines available at every primary, secondary and even tertiary health facilities spread across northwestern Nigeria. Contribution: This study reveals that measles virus circulates with high endemicity in the region, with 50.3% serologically confirmed cases among samples from persons suspected to have measles sent for testing. Additionally, 10.3% of individuals suspected having measles but tested negative were found to test positive for rubella.
- Open Access
- 27 May 2025
- Published by MDPI AG in Microbiology Research
- Vol. 16 (6) , 109
Zika Virus in Malaria-Endemic Populations: A Climate Change-Driven Syndemic in the Sudan Savannah, Nigeria
Zika and malaria are important vector-borne febrile illnesses in humans. In this study, we determined the circulation of Zika virus and malaria infections, their hotspots, and their predominant clinical features. A cross-sectional study was carried out in six Local Government Areas (LGAs) in Kaduna State, Nigeria, from September 2018 to May 2019. Four hundred and twenty sera were screened for Zika virus (ZV) IgM and IgG, and Plasmodium falciparum antigen using ELISA and immunochromatographic test, respectively. Overall, a seroprevalence of 14.5% was found for Zika, and 9.3% for malaria. Nineteen (4.5%) and thirty-five (8.3%) patients were seropositive for ZV IgM and IgG, respectively. Co-infection rates for Zika (ZV IgM) and malaria (0.5%: 2/420), and for ZV IgG and malaria (0.7%: 3/420) were observed. Lere (10%: 7/70 for ZV IgM), Kachia (14.3%: 10/70 for ZV IgG) and Zaria (18.6%: 13/70 for malaria) LGAs were identified as hotspots for Zika and malaria. Age was significantly associated with malaria (p = 0.008) and ZV IgG (p = 0.004). Patients aged 1–10 years had the highest malaria seroprevalence (18.4%), while those aged 21–30 years had the highest ZV IgM prevalence (6.1%: 7/114). Out of the pregnant patients (56/420) tested, 5.37% (3/56) had antibodies to both recent and past ZV infection. A significant association was found between maculopapular rash (p = 0.021) and Zika, as well as between duration of the fever and recent Zika infection (p = 0.041). We highlight that malaria is endemic in Kaduna and that ZV is silently circulating, providing baseline data for further molecular epidemiological studies.
- 27 May 2025
- Published by MDPI AG in Microbiology Research
- Vol. 16 (6) , 109
Open AccessZika Virus in Malaria-Endemic Populations: A Climate Change-Driven Syndemic in the Sudan Savannah, Nigeria
Zika and malaria are important vector-borne febrile illnesses in humans. In this study, we determined the circulation of Zika virus and malaria infections, their hotspots, and their predominant clinical features. A cross-sectional study was carried out in six Local Government Areas (LGAs) in Kaduna State, Nigeria, from September 2018 to May 2019. Four hundred and twenty sera were screened for Zika virus (ZV) IgM and IgG, and Plasmodium falciparum antigen using ELISA and immunochromatographic test, respectively. Overall, a seroprevalence of 14.5% was found for Zika, and 9.3% for malaria. Nineteen (4.5%) and thirty-five (8.3%) patients were seropositive for ZV IgM and IgG, respectively. Co-infection rates for Zika (ZV IgM) and malaria (0.5%: 2/420), and for ZV IgG and malaria (0.7%: 3/420) were observed. Lere (10%: 7/70 for ZV IgM), Kachia (14.3%: 10/70 for ZV IgG) and Zaria (18.6%: 13/70 for malaria) LGAs were identified as hotspots for Zika and malaria. Age was significantly associated with malaria (p = 0.008) and ZV IgG (p = 0.004). Patients aged 1–10 years had the highest malaria seroprevalence (18.4%), while those aged 21–30 years had the highest ZV IgM prevalence (6.1%: 7/114). Out of the pregnant patients (56/420) tested, 5.37% (3/56) had antibodies to both recent and past ZV infection. A significant association was found between maculopapular rash (p = 0.021) and Zika, as well as between duration of the fever and recent Zika infection (p = 0.041). We highlight that malaria is endemic in Kaduna and that ZV is silently circulating, providing baseline data for further molecular epidemiological studies.
- Open Access
- 21 February 2016
- Published by Academic Journals in African Journal of Microbiology Research
- Vol. 10 (7) , 231-237
Antibiogram of bacterial isolates and fungi associated with some creams and lotions sold in Zaria, Nigeria
Skin moisturizing creams and lotions are external preparations that contain special additives that could serve as nutrients for microorganisms; it is possible that such products may get contaminated and serves as vehicles for pathogen transfer. Eight cosmetic products, consisting of 4 body creams and 4 lotions were randomly purchased from the local markets within Zaria and analyzed for their microbiological quality. Five out of the eight products examined were found to be contaminated with bacteria, which had counts ranging from 6.0 × 104 to 5.3 × 105 cfu/g. Three of the products showed evidence of fungal contamination, with counts ranging between 1.3 × 104 and 2.8 × 108 propagules/g. However, three of the products were free from both bacterial and fungal contaminants. Organisms isolated from the creams include Staphylococcus aureus, Bacillus sp., Micrococcus sp., Escherichia coli, Pseudomonas aeruginosa, Aspergillus spp., Mucorand Penicillium spp. The organisms showed a high level of antibiotic resistance. However, erythromycin had the highest activity against the Gram-positive isolates while gentamycin had the highest activity against the Gram-negative isolates. There was significant correlation between microbial contamination and package orifice diameter, with highest bacterial and fungal count observed in products with wider orifices. Based on the U.S. Food and Drug Administration (FDA) and U.S. Pharmacopeial Convention (USP) standard of 103 cfu g−1 for cosmetic products, it was evident that five products had counts above this level; thereby representing serious health hazard. As a result, manufacturers should adhere to good manufacturing practices. Key words: Moisturizing cream, body lotions, microbiological quality, Zaria, Nigeria.
- 21 February 2016
- Published by Academic Journals in African Journal of Microbiology Research
- Vol. 10 (7) , 231-237
Open AccessAntibiogram of bacterial isolates and fungi associated with some creams and lotions sold in Zaria, Nigeria
Skin moisturizing creams and lotions are external preparations that contain special additives that could serve as nutrients for microorganisms; it is possible that such products may get contaminated and serves as vehicles for pathogen transfer. Eight cosmetic products, consisting of 4 body creams and 4 lotions were randomly purchased from the local markets within Zaria and analyzed for their microbiological quality. Five out of the eight products examined were found to be contaminated with bacteria, which had counts ranging from 6.0 × 104 to 5.3 × 105 cfu/g. Three of the products showed evidence of fungal contamination, with counts ranging between 1.3 × 104 and 2.8 × 108 propagules/g. However, three of the products were free from both bacterial and fungal contaminants. Organisms isolated from the creams include Staphylococcus aureus, Bacillus sp., Micrococcus sp., Escherichia coli, Pseudomonas aeruginosa, Aspergillus spp., Mucorand Penicillium spp. The organisms showed a high level of antibiotic resistance. However, erythromycin had the highest activity against the Gram-positive isolates while gentamycin had the highest activity against the Gram-negative isolates. There was significant correlation between microbial contamination and package orifice diameter, with highest bacterial and fungal count observed in products with wider orifices. Based on the U.S. Food and Drug Administration (FDA) and U.S. Pharmacopeial Convention (USP) standard of 103 cfu g−1 for cosmetic products, it was evident that five products had counts above this level; thereby representing serious health hazard. As a result, manufacturers should adhere to good manufacturing practices. Key words: Moisturizing cream, body lotions, microbiological quality, Zaria, Nigeria.
- Open Access
- 1 January 2016
- Published by Medknow in Annals of African Medicine
- Vol. 15 (1) , 20-27
Seroprevalence of hepatitis B virus serological markers among pregnant Nigerian women
Background: Chronic hepatitis B infection is a global problem; however, Asia and sub-Saharan Africa are most affected by it. Hepatitis B status of pregnant women is essential for the effective management of the disease and prevention of mother to child transmission. Materials and Methods: The study was conducted at the antenatal care unit of four hospitals within Kaduna Metropolis, Nigeria, between August and December 2011. After obtaining ethical clearance, blood samples were collected from 800 consenting pregnant women, the plasma were screened for hepatitis B surface antigen (HBsAg) using first response HBsAg card and the reactive sera were confirmed with enzyme-linked immunosorbent assay. Other serological markers of hepatitis B virus (HBV) were detected using the one-step HBV multi-5 test kit. Results: Of the 800 pregnant women screened, 31 (3.9%) tested positive for HBsAg. Only one of the 31 HBsAg positive women had developed the hepatitis B surface antibody, 16 (51.6%) had the envelop antibody, 18 (58.1%) had the hepatitis B core antibody (anti-HBc), and two (6.5%) had hepatitis B envelop antigen (HBeAg). The highest prevalence of HBsAg was recorded among women in age group 21–25 years old (P = 0.968). Similarly, married women (P = 0.772), women in their second trimester of pregnancy (P = 0.938), women with tertiary education (P = 0.972), women from the South-East geopolitical zone (P = 0.250) and those whose husbands were in polygamous relationships (P = 0.944) had the highest seroprevalence of HBsAg. Conclusion: HBV was detected with a prevalence of 3.9% among pregnant women in Kaduna Metropolis, Nigeria. About 96.8% (29) of the reactive women had HBeAg negative chronic hepatitis while 6.5% (2) had HBeAg positive chronic hepatitis B infection. About 58.1% of the women had anti-HBc, hence, did not have immunity and probably had chronic infection with reduced risk of vertical transmission. Pregnant women should be screened for HBsAg at the first antenatal clinic visit for appropriate clinical management and effective prevention of vertical transmission. Résumé Contexte: Hépatite b chronique est un problème mondial ; Toutefois, l'Asie et l'Afrique subsaharienne sont plus touchés par elle. Statut de l'hépatite B des femmes enceintes est essentiel pour la gestion efficace de la maladie et la prévention de la mère à la transmission de l'enfant. Matériels et Méthodes: L'étude a été réalisée à l'unité de soins prénatals de quatre hôpitaux dans la métropole de Kaduna, Nigéria, entre août et décembre 2011. Après avoir obtenu l'autorisation éthique, des échantillons de sang ont été prélevés de 800 femmes enceintes consentantes, le plasma ont été testés pour l'hépatite B antigène de surface (AgHBs) en utilisant la première carte-réponse AgHBs et les sérums réactives ont été confirmé avec épreuve immuno enzymatique. Autres marqueurs sérologiques d'hépatite B (VHB) ont été détectés à l'aide du kit de test multi-5 en une seule étape VHB. Résultats: Des 800 femmes enceintes examinées, 31 (3,9%) étaient positifs pour l'AgHBs. Seulement une des 31 femmes AgHBs positives avait développé les anticorps de surface de l'hépatite B, 16 (51,6%) avaient des anticorps de l'enveloppe, 18 (58,1%) avaient des anticorps contre l'hépatite B (anti-HBc) et deux (6,5%) avait l'hépatite B antigène d'enveloppe (AgHBe). La plus forte prévalence de l'AgHBs a été enregistrée chez les femmes dans la tranche d'âge de 21 à 25 ans (P = 0,968). De même, les femmes mariées (P = 0,772), femmes dans leur deuxième trimestre de la grossesse (P = 0,938), femmes de l'enseignement tertiaire (P = 0.972), les femmes de la zone géopolitique du sud-est (P = 0,250) et celles dont le mari était une relation polygame (P = 0,944) avait la séroprévalence plus élevée de l'AgHBs. Conclusion: VHB a été détectée avec une prévalence de 3,9% chez les femmes enceintes dans la métropole de Kaduna, Nigéria. Environ 96,8% (29) des femmes réactives avaient AgHBe négatif hépatite chronique tandis que 6,5% (2) avaient AgHBe positif de l'hépatite B chronique infection. Environ 58,1% des femmes avaient des anticorps anti-HBc, donc, n'avaient pas d'immunité et avait probablement une infection chronique avec la réduction du risque de transmission verticale. Les femmes enceintes devraient subir de l'AgHBs lors de la première clinique prénatale visite pour la prise en charge clinique appropriée et une prévention efficace de la transmission verticale. Mots-clιs: Surface de l'hιpatite B antigθne, Nigιria, les femmes enceintes des marqueurs sιrologiques, sιroprιvalence
- 1 January 2016
- Published by Medknow in Annals of African Medicine
- Vol. 15 (1) , 20-27
Open AccessSeroprevalence of hepatitis B virus serological markers among pregnant Nigerian women
Background: Chronic hepatitis B infection is a global problem; however, Asia and sub-Saharan Africa are most affected by it. Hepatitis B status of pregnant women is essential for the effective management of the disease and prevention of mother to child transmission. Materials and Methods: The study was conducted at the antenatal care unit of four hospitals within Kaduna Metropolis, Nigeria, between August and December 2011. After obtaining ethical clearance, blood samples were collected from 800 consenting pregnant women, the plasma were screened for hepatitis B surface antigen (HBsAg) using first response HBsAg card and the reactive sera were confirmed with enzyme-linked immunosorbent assay. Other serological markers of hepatitis B virus (HBV) were detected using the one-step HBV multi-5 test kit. Results: Of the 800 pregnant women screened, 31 (3.9%) tested positive for HBsAg. Only one of the 31 HBsAg positive women had developed the hepatitis B surface antibody, 16 (51.6%) had the envelop antibody, 18 (58.1%) had the hepatitis B core antibody (anti-HBc), and two (6.5%) had hepatitis B envelop antigen (HBeAg). The highest prevalence of HBsAg was recorded among women in age group 21–25 years old (P = 0.968). Similarly, married women (P = 0.772), women in their second trimester of pregnancy (P = 0.938), women with tertiary education (P = 0.972), women from the South-East geopolitical zone (P = 0.250) and those whose husbands were in polygamous relationships (P = 0.944) had the highest seroprevalence of HBsAg. Conclusion: HBV was detected with a prevalence of 3.9% among pregnant women in Kaduna Metropolis, Nigeria. About 96.8% (29) of the reactive women had HBeAg negative chronic hepatitis while 6.5% (2) had HBeAg positive chronic hepatitis B infection. About 58.1% of the women had anti-HBc, hence, did not have immunity and probably had chronic infection with reduced risk of vertical transmission. Pregnant women should be screened for HBsAg at the first antenatal clinic visit for appropriate clinical management and effective prevention of vertical transmission. Résumé Contexte: Hépatite b chronique est un problème mondial ; Toutefois, l'Asie et l'Afrique subsaharienne sont plus touchés par elle. Statut de l'hépatite B des femmes enceintes est essentiel pour la gestion efficace de la maladie et la prévention de la mère à la transmission de l'enfant. Matériels et Méthodes: L'étude a été réalisée à l'unité de soins prénatals de quatre hôpitaux dans la métropole de Kaduna, Nigéria, entre août et décembre 2011. Après avoir obtenu l'autorisation éthique, des échantillons de sang ont été prélevés de 800 femmes enceintes consentantes, le plasma ont été testés pour l'hépatite B antigène de surface (AgHBs) en utilisant la première carte-réponse AgHBs et les sérums réactives ont été confirmé avec épreuve immuno enzymatique. Autres marqueurs sérologiques d'hépatite B (VHB) ont été détectés à l'aide du kit de test multi-5 en une seule étape VHB. Résultats: Des 800 femmes enceintes examinées, 31 (3,9%) étaient positifs pour l'AgHBs. Seulement une des 31 femmes AgHBs positives avait développé les anticorps de surface de l'hépatite B, 16 (51,6%) avaient des anticorps de l'enveloppe, 18 (58,1%) avaient des anticorps contre l'hépatite B (anti-HBc) et deux (6,5%) avait l'hépatite B antigène d'enveloppe (AgHBe). La plus forte prévalence de l'AgHBs a été enregistrée chez les femmes dans la tranche d'âge de 21 à 25 ans (P = 0,968). De même, les femmes mariées (P = 0,772), femmes dans leur deuxième trimestre de la grossesse (P = 0,938), femmes de l'enseignement tertiaire (P = 0.972), les femmes de la zone géopolitique du sud-est (P = 0,250) et celles dont le mari était une relation polygame (P = 0,944) avait la séroprévalence plus élevée de l'AgHBs. Conclusion: VHB a été détectée avec une prévalence de 3,9% chez les femmes enceintes dans la métropole de Kaduna, Nigéria. Environ 96,8% (29) des femmes réactives avaient AgHBe négatif hépatite chronique tandis que 6,5% (2) avaient AgHBe positif de l'hépatite B chronique infection. Environ 58,1% des femmes avaient des anticorps anti-HBc, donc, n'avaient pas d'immunité et avait probablement une infection chronique avec la réduction du risque de transmission verticale. Les femmes enceintes devraient subir de l'AgHBs lors de la première clinique prénatale visite pour la prise en charge clinique appropriée et une prévention efficace de la transmission verticale. Mots-clιs: Surface de l'hιpatite B antigθne, Nigιria, les femmes enceintes des marqueurs sιrologiques, sιroprιvalence
- Open Access
- 1 January 2015
- Published by Taylor & Francis in International Journal of Women's Health
- Vol. 7, 75-83
Seroprevalence of rubella-specific IgM and IgG antibodies among pregnant women seen in a tertiary hospital in Nigeria
Background: Rubella is a contagious viral infection that in pregnant women leads to the infection of a developing fetus, causing fetal death or congenital rubella syndrome. Objective: Pregnant women are not routinely screened for rubella in Nigeria. Epidemiological data on rubella is therefore necessary to create awareness and sensitize health care administrators and providers. Materials and methods: A cross-sectional study was carried out at Ahmadu Bello University Teaching Hospital between June and August 2012 to determine the prevalence of immunoglobulin M (IgM) and immunoglobulin G (IgG) antibodies to rubella virus in pregnant women using enzyme-linked immunosorbent assay kits. Seroprevalence was compared among 160 pregnant women attending the antenatal clinic of Ahmadu Bello University Teaching Hospital and 20 nonpregnant women of childbearing age studying at Ahmadu Bello University. Prior to sample collection, questionnaires were administered to the women to obtain data on sociodemographics, awareness and knowledge of rubella, possible risk factors, and clinical symptoms associated with the viral infection. Results: Of the 160 pregnant women, 149 (93.1%) and 62 (38.8%) were positive for anti-rubella IgM and IgG antibodies, respectively. Similarly, of the 20 nonpregnant women, 18 (90%) and eight (40%) were positive for rubella IgG and IgM antibodies, respectively. None of the possible risk factors studied were significantly associated with infection. Age and other sociodemographic factors were of little significance, and awareness of rubella was low. Conclusion: The prevalence of rubella was high in both pregnant (93.1%) and nonpregnant women (90%), suggesting sustained transmission, which further suggests endemicity. The presence of rubella IgM and IgG antibodies in pregnant women predisposes babies to congenital rubella syndrome and emphasizes the need for the initiation of a national rubella vaccination program in Nigeria.
- 1 January 2015
- Published by Taylor & Francis in International Journal of Women's Health
- Vol. 7, 75-83
Open AccessSeroprevalence of rubella-specific IgM and IgG antibodies among pregnant women seen in a tertiary hospital in Nigeria
Background: Rubella is a contagious viral infection that in pregnant women leads to the infection of a developing fetus, causing fetal death or congenital rubella syndrome. Objective: Pregnant women are not routinely screened for rubella in Nigeria. Epidemiological data on rubella is therefore necessary to create awareness and sensitize health care administrators and providers. Materials and methods: A cross-sectional study was carried out at Ahmadu Bello University Teaching Hospital between June and August 2012 to determine the prevalence of immunoglobulin M (IgM) and immunoglobulin G (IgG) antibodies to rubella virus in pregnant women using enzyme-linked immunosorbent assay kits. Seroprevalence was compared among 160 pregnant women attending the antenatal clinic of Ahmadu Bello University Teaching Hospital and 20 nonpregnant women of childbearing age studying at Ahmadu Bello University. Prior to sample collection, questionnaires were administered to the women to obtain data on sociodemographics, awareness and knowledge of rubella, possible risk factors, and clinical symptoms associated with the viral infection. Results: Of the 160 pregnant women, 149 (93.1%) and 62 (38.8%) were positive for anti-rubella IgM and IgG antibodies, respectively. Similarly, of the 20 nonpregnant women, 18 (90%) and eight (40%) were positive for rubella IgG and IgM antibodies, respectively. None of the possible risk factors studied were significantly associated with infection. Age and other sociodemographic factors were of little significance, and awareness of rubella was low. Conclusion: The prevalence of rubella was high in both pregnant (93.1%) and nonpregnant women (90%), suggesting sustained transmission, which further suggests endemicity. The presence of rubella IgM and IgG antibodies in pregnant women predisposes babies to congenital rubella syndrome and emphasizes the need for the initiation of a national rubella vaccination program in Nigeria.
- Open Access
- 1 May 2014
- Published by Taylor & Francis in International Journal of Women's Health
- Vol. 6, 479-487
Seroprevalence of human papillomavirus immunoglobulin G antibodies among women presenting at the reproductive health clinic of a university teaching hospital in Nigeria
Background: Human papillomavirus (HPV) is the cause of 90%–95% of squamous cell cancers. Persistent infection with high-risk HPV can lead to development of precancerous lesions of the cervix in 5%–10% of infected women, and can progress to invasive cervical cancer 15–20 years later. This study was conducted to determine the seroprevalence of HPV immunoglobulin G (IgG) antibodies among women of reproductive age attending a reproductive health clinic at Ahmadu Bello University Teaching Hospital, Zaria, Nigeria. Methods: The study was descriptive, cross-sectional, and experimental, combining the use of a structured questionnaire and analysis of serum samples obtained from 350 consecutive consenting women. The serum samples were analyzed for IgG antibodies to HPV by enzyme-linked immunosorbent assay. Results: We found a seroprevalence of 42.9% (150/350) for IgG antibodies to HPV in these women. Women aged 45–49 years and those who had their sexual debut aged 20–23 years had the highest HPV seroprevalence, ie, 50% (57/114) and 51.1% (46/90), respectively. Presence of antibodies varied according to sociodemographic factors, but was significantly associated with educational status, tribe, and religion (P0.05). Conclusion: Further studies are needed to determine the HPV serotypes and evaluate the risk of natural development of HPV-related malignancies among women in the study area.
- 1 May 2014
- Published by Taylor & Francis in International Journal of Women's Health
- Vol. 6, 479-487
Open AccessSeroprevalence of human papillomavirus immunoglobulin G antibodies among women presenting at the reproductive health clinic of a university teaching hospital in Nigeria
Background: Human papillomavirus (HPV) is the cause of 90%–95% of squamous cell cancers. Persistent infection with high-risk HPV can lead to development of precancerous lesions of the cervix in 5%–10% of infected women, and can progress to invasive cervical cancer 15–20 years later. This study was conducted to determine the seroprevalence of HPV immunoglobulin G (IgG) antibodies among women of reproductive age attending a reproductive health clinic at Ahmadu Bello University Teaching Hospital, Zaria, Nigeria. Methods: The study was descriptive, cross-sectional, and experimental, combining the use of a structured questionnaire and analysis of serum samples obtained from 350 consecutive consenting women. The serum samples were analyzed for IgG antibodies to HPV by enzyme-linked immunosorbent assay. Results: We found a seroprevalence of 42.9% (150/350) for IgG antibodies to HPV in these women. Women aged 45–49 years and those who had their sexual debut aged 20–23 years had the highest HPV seroprevalence, ie, 50% (57/114) and 51.1% (46/90), respectively. Presence of antibodies varied according to sociodemographic factors, but was significantly associated with educational status, tribe, and religion (P0.05). Conclusion: Further studies are needed to determine the HPV serotypes and evaluate the risk of natural development of HPV-related malignancies among women in the study area.
- Open Access
- 1 September 2010
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 202 (S1) , S198-S204
Diversity of Rotavirus VP7 and VP4 Genotypes in Northwestern Nigeria
Background. Nigeria has recently been ranked third among the 10 countries with the greatest number of rotavirus disease-associated deaths per year. E
- 1 September 2010
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 202 (S1) , S198-S204
Open AccessDiversity of Rotavirus VP7 and VP4 Genotypes in Northwestern Nigeria
Background. Nigeria has recently been ranked third among the 10 countries with the greatest number of rotavirus disease-associated deaths per year. E
- Open Access
- 3 December 2008
- Published by Oxford University Press (OUP) in Journal of Tropical Pediatrics
- Vol. 55 (3) , 192-194
Role of Astrovirus in Intussusception in Nigerian infants
Intussusception (IS) is a form of intestinal obstruction in which a segment of the bowel prolapses into a more distal segment. Viral infections, mostly adenovirus, enteroviruses, human herpesvirus and Epstein–Barr virus are reported in 20–50% of childhood cases of IS. Between January and July 2004, six stool specimens collected from infants 0- to 8-months old diagnosed and admitted for IS were investigated for the presence of rotavirus, astrovirus and adenovirus antigens. Astrovirus antigen was detected in three of the six stool specimens by enzyme immune assay (EIA) and confirmed in two specimens by reverse transcription–polymerase chain reaction (RT–PCR). Rotavirus, non-enteric adenovirus and astrovirus were detected by EIA, as mixed infections in a single specimen. The rotavirus strain revealed a SGI+II, mixed G1G2G8P[6] genotype and had no visible electrophoretic profile. A larger study is needed to determine the extent of involvement of astroviruses in IS in infants and the virus should be included in studies investigating the aetiology of IS.
- 3 December 2008
- Published by Oxford University Press (OUP) in Journal of Tropical Pediatrics
- Vol. 55 (3) , 192-194
Open AccessRole of Astrovirus in Intussusception in Nigerian infants
Intussusception (IS) is a form of intestinal obstruction in which a segment of the bowel prolapses into a more distal segment. Viral infections, mostly adenovirus, enteroviruses, human herpesvirus and Epstein–Barr virus are reported in 20–50% of childhood cases of IS. Between January and July 2004, six stool specimens collected from infants 0- to 8-months old diagnosed and admitted for IS were investigated for the presence of rotavirus, astrovirus and adenovirus antigens. Astrovirus antigen was detected in three of the six stool specimens by enzyme immune assay (EIA) and confirmed in two specimens by reverse transcription–polymerase chain reaction (RT–PCR). Rotavirus, non-enteric adenovirus and astrovirus were detected by EIA, as mixed infections in a single specimen. The rotavirus strain revealed a SGI+II, mixed G1G2G8P[6] genotype and had no visible electrophoretic profile. A larger study is needed to determine the extent of involvement of astroviruses in IS in infants and the virus should be included in studies investigating the aetiology of IS.